✦ LIBER ✦

Pharmacokinetics of high-dose cyclophosphamide in patients with metastatic bronchogenic carcinoma

✍ Scribed by P. M. Wilkinson; P. A. O'Neill; N. Thatcher; S. B. Lucas

Publisher: Springer
Year: 1983
Tongue: English
Weight: 403 KB
Volume: 11
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00254204

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cyclophosphamide pharmacokinetics and do

Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency

✍ Haubitz, Marion; Bohnenstengel, Frank; Brunkhorst, Reinhard; Schwab, Matthias; H 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 219 KB

## Background: Intravenous pulse administration of cyclophosphamide (cyc) has been successfully used for the treatment of various autoimmune diseases. these patients often present with impaired renal function or even end-stage renal failure. nevertheless, data concerning pharmacokinetics of cyc in

Treatment of patients with pineoblastoma

Treatment of patients with pineoblastoma with high dose cyclophosphamide

✍ Ashley, David M.; Longee, Daryll; Tien, Robert; Fuchs, Herbert; Graham, Michael 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 639 KB

The outcome for patients with pineoblastoma has historically been very poor, with most patients dying of disseminated disease despite irradiation. Furthermore, the low incidence of this tumor has hindered progress toward defining better treatment strategies. Here we report the activity and toxicity

Comparative pharmacokinetics of escalati

Comparative pharmacokinetics of escalating doses of doxorubicin in patients with metastatic breast cancer

✍ Miguel H. Bronchud; Jennifer M. Margison; Anthony Howell; Michael Lind; Samuel B 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 472 KB

High-dose doxorubicin, etoposide, and cy

High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer

✍ George Somlo; James H. Doroshow; Stephen J. Forman; Lucille A. Leong; Kim A. Mar 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 780 KB

Multiple-dose pharmacokinetics of epirub

Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancer

✍ Preben Jakobsen; Eva Steiness; Lars Bastholt; Mads Dalmark; Anders Lorenzen; Dor 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 549 KB

A Phase I and pharmacokinetic study of h

A Phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanoma

✍ Edward F. McClay; Mary-Eileen T. McClay; Jeffery A. Jones; Paul J. Winski; Rando 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

by 40 mg to the MTD in groups of 3 patients. DDP (80 mg/m 2 ) was begun on Day ogy/Oncology, Hollings Cancer Center, Medical 2 and repeated weekly for a total of 3 weeks. During Week 4, the patients were University of South Carolina, Charleston, South not treated with DDP but instead evaluated for r